SUNeVision Holdings Ltd (1686)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 4.870 |
|---|---|
| 52-week range | 4.240 – 7.900 |
| Return, 1 month / 3 months | −13.7% / +3.4% |
| Return, 1 year / 3 years | −20.5% / +72.9% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 53.7% |
| Worst drawdown (1 year) | -40.6% |
| Average daily value traded | 24.96M HKD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SUNeVision Holdings is a Hong Kong based technology company that operates data centres and provides related services to enterprises. Through its data centre business, it offers colocation, managed hosting and connectivity services to corporate customers, carriers and cloud providers. The company also supplies fibre-optic network links and cloud-related support, serving businesses that need secure space and reliable connections for their computing equipment in Hong Kong.
SUNeVision Holdings Ltd trades under the code 1686 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SUNeVision Holdings Ltd (1686) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 4.870 on 27 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 926 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.5% and over the last three months it rose 3.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -13.8% | ||
| From 52-week high | -33.5% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.4% | ||
| 6-month return | -21.6% | ||
| 12-month return, skipping the last month | -7.9% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 53.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.6% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 24.96M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −6.5% |
|---|---|
| 1 month | −13.7% |
| 3 months | +3.4% |
| 6 months | −21.6% |
| 1 year | −20.5% |
| 3 years | +72.9% |
| 5 years | −19.3% |
Signals
| 50-day / 200-day average | 5.318 / 5.651 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.199 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Nov 2025 | HKD 0.1200 |
| 5 Nov 2024 | HKD 0.1120 |
| 31 Oct 2023 | HKD 0.1120 |
| 1 Nov 2022 | HKD 0.2080 |
| 2 Nov 2021 | HKD 0.1940 |
| 3 Nov 2020 | HKD 0.1750 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.